Dear Friend,

This month, Democracy Now! turns 25—that’s 25 years of bringing you the voices and stories you won’t hear in the corporate media. Democracy Now! has always refused to take government or corporate funding, because nothing is more important to us than our editorial independence. Nothing is more important to us than telling you the truth. But that means we rely on you, our audience, for support. Please make your contribution of $25 or more in honor of our 25th anniversary and help us stay on air for another 25 years. Right now, a generous donor will even DOUBLE your gift, which means it’ll go twice as far! This is a challenging time for us all, but if you're able to make a donation, please do so today. Thank you and remember, wearing a mask is an act of love. Wearing two is even better.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

High-Ranking Pharma Exec Sentenced to 5.5 Years for Role in Opioid Crisis

HeadlineJan 27, 2020

In Boston, the founder of Insys Therapeutics has been sentenced to five-and-a-half years in prison in a landmark case for the opioid crisis. John Kapoor and four other executives were convicted last May of a criminal conspiracy to bribe doctors to prescribe a highly addictive fentanyl spray to patients who didn’t need it. One of the defendants allegedly gave a lap dance to a doctor at a company event in order to persuade him to prescribe the drug. Legal experts say the sentencing should be a warning to other drug company executives who have engaged in deceptive marketing practices and other schemes to push opioids.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top